{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:27:25Z","timestamp":1787758045762,"version":"build-2784847793"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Hair loss is one of the most common post-covid symptoms observed during this severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Pro-inflammatory cytokines, direct viral effect on hair follicles, and microthrombi are thought to be the pathogenic factors considered. Information regarding time of onset and severity is similar to other infection-induced acute telogen effluvium. It is reasonable to think that the evolution and prognosis are similar, and therefore, even without any specific treatment, full recovery of lost hair is expected.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/idoj.idoj_139_22","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T04:22:48Z","timestamp":1656044568000},"page":"445-448","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Covid Induced Telogen Effluvium (CITE)"],"prefix":"10.4103","volume":"13","author":[{"given":"Arun C.","family":"Inamadar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-1-20240828","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent symptoms in patients after acute COVID-19","volume":"324","author":"Carf\u00ec","year":"2020","journal-title":"JAMA"},{"key":"R3-1-20240828","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.NPR.0000794520.66134.e4","article-title":"Post-COVID conditions-What practitioners need to know","volume":"46","author":"Waterbury","year":"2021","journal-title":"Nurse Pract"},{"key":"R4-1-20240828","doi-asserted-by":"crossref","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","article-title":"More than 50 long-term effects of COVID-19:A systematic review and meta-analysis","volume":"11","author":"Lopez-Leon","year":"2021","journal-title":"Sci Rep"},{"key":"R5-1-20240828","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12916-021-02115-0","article-title":"Evolving phenotypes of non-hospitalized patients that indicate long COVID","volume":"19","author":"Estiri","year":"2021","journal-title":"BMC Med"},{"key":"R6-1-20240828","first-page":"e18568","article-title":"Clinical characteristics of Japanese patients who visited a COVID-19 aftercare clinic for post-acute sequelae of COVID-19\/Long COVID","volume":"13","author":"Otsuka","year":"2021","journal-title":"Cureus"},{"key":"R7-1-20240828","first-page":"e8320","article-title":"Telogen effluvium:A review of the literature","volume":"12","author":"Asghar","year":"2020","journal-title":"Cureus"},{"key":"R9-1-20240828","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/ijd.15313","article-title":"Telogen effluvium:A sequela of COVID-19","volume":"60","author":"Mieczkowska","year":"2021","journal-title":"Int J Dermatol"},{"key":"R10-1-20240828","first-page":"e14547","article-title":"Telogen effluvium related to post severe Sars-Cov-2 Infection:Clinical aspects and our management experience","volume":"34","author":"Giulio","year":"2021","journal-title":"Dermatol Ther"},{"key":"R11-1-20240828","doi-asserted-by":"crossref","first-page":"67","DOI":"10.12788\/j.sder.2015.0142","article-title":"Female pattern alopecia and telogen effluvium:Figuring out diffuse alopecia","volume":"34","author":"Torres","year":"2015","journal-title":"Semin Cutan Med Surg"},{"key":"R12-1-20240828","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000247518","article-title":"Telogen effluvium due to recombinant interferon alpha-2b","volume":"184","author":"Tosti","year":"1992","journal-title":"Dermatology"},{"key":"R13-1-20240828","first-page":"432","article-title":"Interleukin-4 induces apoptosis in cultured human follicular keratinocytes, but not in dermal papilla cells","volume":"12","author":"Mandt","year":"2002","journal-title":"Eur J Dermatol"},{"key":"R14-1-20240828","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/jir.1997.17.151","article-title":"Interleukin-1beta is differentially expressed by human dermal papilla cells in response to PKC activation and is a potent inhibitor of human hair follicle growth in organ culture","volume":"17","author":"Xiong","year":"1997","journal-title":"J Interferon Cytokine Res"},{"key":"R16-1-20240828","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/cyto.a.24047","article-title":"Dengue fever, COVID-19 (SARS-CoV-2), and antibody-dependent enhancement (ADE):A perspective","volume":"97","author":"Ulrich","year":"2020","journal-title":"Cytometry A"},{"key":"R17-1-20240828","first-page":"1","article-title":"Telogen Effluvium after SARS-CoV-2 infection:A series of cases and possible pathogenetic mechanisms","volume":"21","author":"Rossi","year":"2021","journal-title":"Skin Appendage Disord"},{"key":"R18-1-20240828","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1080\/21645515.2020.1796425","article-title":"Role of antibody-dependent enhancement (ADE) in the virulence of SARSCoV- 2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19","volume":"16","author":"Karthik","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"R19-1-20240828","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","article-title":"COVID-19 cytokine storm:The interplay between inflammation and coagulation","volume":"8","author":"Jose","year":"2020","journal-title":"Lancet Respir Med"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_139_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:01:41Z","timestamp":1787756501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_139_22"}},"subtitle":["An Insight"],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_139_22","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}